THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β-blocker, atenolol, in patients with arterial hypertension (HT) 1-2 degree com- pared to fixed combination of racemic amlodipine and atenolol.Material and methods. Patients (n=31, 7 men and 24 women) wit...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | https://www.rpcardio.com/jour/article/view/47 |
id |
doaj-2c22608c13f044658c17b64c5257c36b |
---|---|
record_format |
Article |
spelling |
doaj-2c22608c13f044658c17b64c5257c36b2021-09-03T13:15:11ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-09-019323624010.20996/1819-6446-2013-9-3-236-24046THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERSM. A. Maksimova0Yu. V. Lukina1S. Yu. Martsevich2State Research Center for Preventive Medicine, MoscowState Research Center for Preventive Medicine, MoscowState Research Center for Preventive Medicine, I.M. Sechenov First Moscow State Medical University, MoscowAim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β-blocker, atenolol, in patients with arterial hypertension (HT) 1-2 degree com- pared to fixed combination of racemic amlodipine and atenolol.Material and methods. Patients (n=31, 7 men and 24 women) with HT 1–2 degree were included into the study. The patients were randomized into two groups by the com- binations sequence. Treatment with each combination lasted 4 weeks. Office blood pressure (BP) was assessed at baseline and at the end of the treatment periods, possible side effects were registered.Results. All patients completed the study. Both combination of S-amlodipine+atenolol and fixed combination of racemic amlodipine+atenolol reduced systolic (in average, -15.9 and -12.7 mm Hg, respectively) and diastolic (in average, -7.3 and -5.3 mmHg, respectively) BP significantly. Heart rate also decreased during therapy (in average, -3 and -4 bt/min, respectively). The differences between combinations BP and heart rate effects were not significant. 8 and 16 adverse events were registered during S-amlodipine+atenolol and racemic amlodipine+atenolol therapies, respectively Conclusion. Combination of S-amlodipine+atenolol, as well as combination of racemic amlodipine+atenolol are effective in the treatment of patients with HT 1-2 degree, however combination with S-amlodipine has less number of adverse events.https://www.rpcardio.com/jour/article/view/47arterial hypertensioncombination therapys-amlodipineβ-blockerracemic amlodipine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
M. A. Maksimova Yu. V. Lukina S. Yu. Martsevich |
spellingShingle |
M. A. Maksimova Yu. V. Lukina S. Yu. Martsevich THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS Racionalʹnaâ Farmakoterapiâ v Kardiologii arterial hypertension combination therapy s-amlodipine β-blocker racemic amlodipine |
author_facet |
M. A. Maksimova Yu. V. Lukina S. Yu. Martsevich |
author_sort |
M. A. Maksimova |
title |
THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS |
title_short |
THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS |
title_full |
THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS |
title_fullStr |
THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS |
title_full_unstemmed |
THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS |
title_sort |
role of s-amlodipine in arterial hypertension therapy with combination of calcium channel blockers and beta-blockers |
publisher |
Stolichnaya Izdatelskaya Kompaniya |
series |
Racionalʹnaâ Farmakoterapiâ v Kardiologii |
issn |
1819-6446 2225-3653 |
publishDate |
2015-09-01 |
description |
Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β-blocker, atenolol, in patients with arterial hypertension (HT) 1-2 degree com- pared to fixed combination of racemic amlodipine and atenolol.Material and methods. Patients (n=31, 7 men and 24 women) with HT 1–2 degree were included into the study. The patients were randomized into two groups by the com- binations sequence. Treatment with each combination lasted 4 weeks. Office blood pressure (BP) was assessed at baseline and at the end of the treatment periods, possible side effects were registered.Results. All patients completed the study. Both combination of S-amlodipine+atenolol and fixed combination of racemic amlodipine+atenolol reduced systolic (in average, -15.9 and -12.7 mm Hg, respectively) and diastolic (in average, -7.3 and -5.3 mmHg, respectively) BP significantly. Heart rate also decreased during therapy (in average, -3 and -4 bt/min, respectively). The differences between combinations BP and heart rate effects were not significant. 8 and 16 adverse events were registered during S-amlodipine+atenolol and racemic amlodipine+atenolol therapies, respectively Conclusion. Combination of S-amlodipine+atenolol, as well as combination of racemic amlodipine+atenolol are effective in the treatment of patients with HT 1-2 degree, however combination with S-amlodipine has less number of adverse events. |
topic |
arterial hypertension combination therapy s-amlodipine β-blocker racemic amlodipine |
url |
https://www.rpcardio.com/jour/article/view/47 |
work_keys_str_mv |
AT mamaksimova theroleofsamlodipineinarterialhypertensiontherapywithcombinationofcalciumchannelblockersandbetablockers AT yuvlukina theroleofsamlodipineinarterialhypertensiontherapywithcombinationofcalciumchannelblockersandbetablockers AT syumartsevich theroleofsamlodipineinarterialhypertensiontherapywithcombinationofcalciumchannelblockersandbetablockers AT mamaksimova roleofsamlodipineinarterialhypertensiontherapywithcombinationofcalciumchannelblockersandbetablockers AT yuvlukina roleofsamlodipineinarterialhypertensiontherapywithcombinationofcalciumchannelblockersandbetablockers AT syumartsevich roleofsamlodipineinarterialhypertensiontherapywithcombinationofcalciumchannelblockersandbetablockers |
_version_ |
1717817183135858688 |